What Is A Value Based Agreement

Reducing drug costs – In a value-based contracting process, manufacturers can pay higher discounts to patients who fail to meet agreed outcome targets, which could reduce drug costs. Reducing medical costs – By improving disease control, a value-based order could reduce medical costs by reducing hospitalizations, emergency visits, etc. Deloitte has the breadth and depth of skills to help the health and life sciences sectors overcome these barriers. Our value-based care practice, recognized several times by KLAS as a leader in our field, serves as a trusted intermediary for multi-party contracts. We take a healthy mix of inter-functional perspectives, from actuaries to data scientists, from industrial consultants to technologists, to facilitate the necessary changes in volume to value-based sourcing. Our approach below includes a contracting strategy based on value and implementation of agreements in an end-to-end lifecycle. The ConvergeHEALTH platform is a secure cloud-based big data environment that aims to streamline the entire VBC process from start to finish. The platform can process the most complex health data, increase efficiency and economies of scale for VBCs, while building trust through transparency and objectivity. itemImage: “-item-2-image,” itemImageRight: “item-2-image-right,” itemMoreTexte: “-item-2-read-more-text,” itemMoreURL: item-2-read-more-url`, itemVideoURL: “-item-2-video-url,” itemInfographicUrl: “-item-2-infographic-url” -Item 3 daccordItems[2] – itemOpen: “-item-3-open item,”Tit “Patient and Commitment Provider,” itemText: “The value contract, also known as results-based contracting, is a kind of payment model that links the price of a drug to the performance of a drug. This is in stark contradiction to other payment models in the health sector, where drug prices are determined by data collected during clinical trials, a controlled environment that is not always followed by real-world performance. So how do value-based contract models work? It`s easy. When a drug performs, payers (insurers, supplier networks) pay the full price.

If this is not the case, the payer may receive refunds or rebates from the manufacturer.